SachinKShahMD

Pediatric Critical Care Medicine

Vice President of Clinical Development

Dr. Shah is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
Innovative Medical Solutions
1007 Alameda Blvd
Troy, MI 48085
Phone+1 773-636-9945

University of MichiganFellowship, Pediatric Critical Care Medicine, 2012 - 2013
Tufts Medical CenterResidency, Pediatrics, 2004 - 2007
Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 2004
Brandeis UniversityB.S./B.A., Neuroscience/Biology, Psychology, 1995 - 1999

Abstracts/Posters

A novel oral tubulin inhibitor: Safety and preliminary efficacy of two Phase I studies with indibulin.
Chawla S, Chua V, Abbadessa G, Shah S, Nichols S, Rosen L, Second AACR Centennial Conference on Translational Cancer Medicine, Monterey, CA, 7/20/2008
A Phase II trial of Darinaparsin in advanced lymphomas: report on safety and efficacy.
Craig M, Tallman M, Shah S, Lewis J, Lossos I, ASH, 1/1/2008
Phase II trial of Darinaparsin (ZIO-101) in Leukemias and Lymphomas.
Craig M, Tallman M, Boccia R, Schwartz B, Shah SK, Lossos IS, AACR, 1/1/2008